SNX14
Basic information
Region (hg38): 6:85504776-85594156
Links
Phenotypes
GenCC
Source:
- autosomal recessive spinocerebellar ataxia 20 (Strong), mode of inheritance: AR
- autosomal recessive spinocerebellar ataxia 20 (Supportive), mode of inheritance: AR
- autosomal recessive spinocerebellar ataxia 20 (Strong), mode of inheritance: AR
- autosomal recessive spinocerebellar ataxia 20 (Strong), mode of inheritance: AR
- autosomal recessive spinocerebellar ataxia 20 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spinocerebellar ataxia, autosomal recessive 20 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 24501761; 25439728; 25848753 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (201 variants)
- Inborn_genetic_diseases (92 variants)
- Autosomal_recessive_spinocerebellar_ataxia_20 (44 variants)
- SNX14-related_disorder (15 variants)
- Neurodevelopmental_disorder (2 variants)
- not_specified (2 variants)
- Cerebellar_ataxia (1 variants)
- Spinocerebellar_atrophy (1 variants)
- Seizure (1 variants)
- Global_developmental_delay (1 variants)
- Abnormal_brain_morphology (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SNX14 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000153816.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 38 | 42 | ||||
missense | 132 | 138 | ||||
nonsense | 13 | |||||
start loss | 0 | |||||
frameshift | 14 | |||||
splice donor/acceptor (+/-2bp) | 12 | 15 | ||||
Total | 17 | 26 | 135 | 42 | 2 |
Highest pathogenic variant AF is 0.0000477869
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SNX14 | protein_coding | protein_coding | ENST00000314673 | 29 | 88661 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.07e-17 | 0.982 | 125650 | 0 | 98 | 125748 | 0.000390 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.85 | 350 | 462 | 0.758 | 0.0000218 | 6215 |
Missense in Polyphen | 87 | 141.32 | 0.61564 | 1963 | ||
Synonymous | -0.719 | 169 | 158 | 1.07 | 0.00000731 | 1692 |
Loss of Function | 2.61 | 35 | 56.1 | 0.624 | 0.00000270 | 748 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000525 | 0.000516 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00122 | 0.00114 |
Finnish | 0.000144 | 0.000139 |
European (Non-Finnish) | 0.000437 | 0.000422 |
Middle Eastern | 0.00122 | 0.00114 |
South Asian | 0.000405 | 0.000392 |
Other | 0.000336 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in maintaining normal neuronal excitability and synaptic transmission. May be involved in several stages of intracellular trafficking (By similarity). Required for autophagosome clearance, possibly by mediating the fusion of lysosomes with autophagosomes (Probable). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), a key component of late endosomes/lysosomes (PubMed:25848753). Does not bind phosphatidylinositol 3-phosphate (PtdIns(3P)) (PubMed:25848753, PubMed:25148684). {ECO:0000250|UniProtKB:Q8BHY8, ECO:0000269|PubMed:25148684, ECO:0000269|PubMed:25848753, ECO:0000305|PubMed:25848753}.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.964
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.65
Haploinsufficiency Scores
- pHI
- 0.168
- hipred
- Y
- hipred_score
- 0.536
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.508
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Snx14
- Phenotype
Zebrafish Information Network
- Gene name
- snx14
- Affected structure
- neuron
- Phenotype tag
- abnormal
- Phenotype quality
- apoptotic
Gene ontology
- Biological process
- protein transport;autophagosome maturation
- Cellular component
- lysosome;lysosomal membrane;late endosome;integral component of membrane;dendrite;late endosome membrane
- Molecular function
- phosphatidylinositol-3,5-bisphosphate binding